Term
| Insulin w/ On = <15 mins. |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Intermediate - Lente, NPH |
|
|
Term
|
Definition
|
|
Term
| Insulin w/ Dur = 4 or < hrs. |
|
Definition
|
|
Term
| Insulin w/ Dur. = 3-6 hrs. |
|
Definition
|
|
Term
| Insulin w/ Dur = 10-16 hrs. |
|
Definition
| Intermediate - Lente, NPH |
|
|
Term
|
Definition
|
|
Term
| Insulin w/ Peak = 60-90 mins |
|
Definition
|
|
Term
| Insulin w/ Peak = 2-3 hrs. |
|
Definition
|
|
Term
| Insulin w/ Peak = 4-10 hrs. |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Only insulin that can be given IV push |
|
Definition
|
|
Term
| 1st line treatment for DKA |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| ? Insulin = Never mix with any other insulin |
|
Definition
|
|
Term
| Onset - Rapid Acting Insulin |
|
Definition
|
|
Term
| Peak - Rapid Acting Insulin |
|
Definition
|
|
Term
| Duration - Rapid Acting Insulin |
|
Definition
|
|
Term
| Onset - REgular Acting Insulin |
|
Definition
|
|
Term
| Peak - Regular ACting Insulin |
|
Definition
|
|
Term
| Duration - Regular Acting Insulin |
|
Definition
|
|
Term
| Onset - Intermed. Act. Insulin |
|
Definition
|
|
Term
| Peak - Intermed. Act. Insulin |
|
Definition
|
|
Term
| Duration - Intermed. Act. Insulin |
|
Definition
|
|
Term
| Onset - Long Acting Insulin |
|
Definition
|
|
Term
| Peak - Long Acting Insulin |
|
Definition
|
|
Term
| Duration - Long Acting Insulin |
|
Definition
|
|
Term
| OHA to avoid for pregnancy |
|
Definition
|
|
Term
| OHA to avoid for Breastfeeding |
|
Definition
|
|
Term
| OHA to avoid for Allergic to Sulfa |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| ? OHA = repaglinide/Prandin |
|
Definition
|
|
Term
| ? OHA = nateglinide/Starlix |
|
Definition
|
|
Term
| OHA - may skip if not eating |
|
Definition
|
|
Term
| ? OHA = Metformin/Glucophage |
|
Definition
|
|
Term
| OHA - Don't use with Iodine |
|
Definition
|
|
Term
| OHA - used to prevent Type 2 diabetes at pre-diabetes level |
|
Definition
|
|
Term
| ? OHA - MOA - 1.Works mainly in liver & muscle; 2. REduces hepatic glucose production; 3. Increases glucose uptake by muscle, liver & adipose tissue |
|
Definition
|
|
Term
| ? OHA - use alone or in combo. w/ sulfonylureas |
|
Definition
|
|
Term
| ? OHA - aka starch blockers |
|
Definition
| Alpha-Glucosidase Inhibitors |
|
|
Term
|
Definition
| Alpha-Glucosidase Inhibitors |
|
|
Term
|
Definition
| Alpha-Glucosidase Inhibitors |
|
|
Term
| ? OHA = Take with 1st bite of each main meal |
|
Definition
| Alpha-Glucosidase Inhibitor - Precose |
|
|
Term
| ? OHA = most effective at lowering post-prandial glucose levels |
|
Definition
| Alpha-Glucosidase Inhibitors |
|
|
Term
|
Definition
|
|
Term
| ? OHA = Actos/Ploglitazones |
|
Definition
| Thiazolidinediones/glitazones |
|
|
Term
| ? OHA = Avandia/Rosiglitazone |
|
Definition
| Thiazolidinediones/glitazones |
|
|
Term
| ? OHA = decreases effectiveness of oral contraceptives |
|
Definition
| Thiazolidinediones/glitazones - Avandia |
|
|
Term
| ? OHA = Do not use for pts. w/ Heart Failure |
|
Definition
| Thiazolidinediones/glitazones - Avandia |
|
|
Term
| Hormone released from small intestine, that stimulates pancreas to release insulin |
|
Definition
|
|
Term
| Hormone normally released by Beta Cells of Pancreas, co-released with Insulin after food intake |
|
Definition
|
|
Term
| ? OHA = Januvia/Sitagliptin |
|
Definition
| Dipeptidyl Peptidase 4 Inhibitors |
|
|
Term
| ? OHA = Galvus/Vildagliptin |
|
Definition
| Dipeptidyl Peptidase 4 Inhibitors |
|
|
Term
| ? OHA - Makes Incretin stay "on board" longer in order to stimulate pancreas to release insulin |
|
Definition
| Dipeptidyl Peptidase 4 Inhibitors |
|
|
Term
| ? Other = Symlin/Pramlintide |
|
Definition
|
|
Term
| ? Other w/MOA = 1.Delays gastric emptying; 2.Decreases post-prandial glucagon secretion; 3. Increases Satiety, decreases calroic intake |
|
Definition
|
|
Term
| ? Other - used for Type I & Type II who have not acheived glucose control even after taking insulin at mealtimes |
|
Definition
|
|
Term
| ? Other = Exanatide/Byetta |
|
Definition
|
|
Term
| ? Other = Adjunct therapy for Type 2 |
|
Definition
|
|
Term
| ? Other = not used with insulin |
|
Definition
|
|
Term
| Exenatide/Byetta - how to give? |
|
Definition
|
|
Term
| Symlin/pramlintide - how to give? |
|
Definition
|
|
